Coffee and tea breaks for liver health

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
MELD: the holy grail of organ allocation?
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Volume 61, Issue 6, Pages (December 2014)
Volume 51, Issue 6, Pages (December 2009)
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Immigration and viral hepatitis
Volume 66, Issue 1, Pages 1-4 (January 2017)
The evidence supports a viral aetiology for primary biliary cirrhosis
Living donor liver transplantation: is the hype over?
Nicolas Moniaux, Jamila Faivre  Journal of Hepatology 
Mesenchymal stromal cell therapy for liver diseases
Reply to: “DCD consensus and futility in liver transplantation”
Volume 69, Issue 2, Pages (August 2018)
The place of downstaging for hepatocellular carcinoma
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Amalia Gastaldelli, Giulio Marchesini  Journal of Hepatology 
Volume 70, Issue 1, Pages (January 2019)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Autophagy in the liver Journal of Hepatology
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Use of hemospray for non-variceal esophageal bleeding in an infant
The changing role of beta-blocker therapy in patients with cirrhosis
Volume 57, Issue 5, Pages (November 2012)
Volume 50, Issue 4, Pages (April 2009)
Volume 69, Issue 5, Pages (November 2018)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Chetana Lim, Chady Salloum, Daniel Azoulay
Immigration and viral hepatitis
Evolution of liver transplantation for hepatocellular carcinoma
The potential of induced pluripotent stem cell derived hepatocytes
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
Volume 51, Issue 2, Pages (August 2009)
The use of hemospray in portal hypertensive bleeding; a case series
Volume 62, Issue 3, Pages (March 2015)
Volume 66, Issue 4, Pages (April 2017)
New trials and results in systemic treatment of HCC
Liver transplantation in children
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
The relationship between age and fat infiltration in liver and muscle
Genetics of hepatocellular carcinoma: The next generation
MELD: the holy grail of organ allocation?
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Volume 64, Issue 6, Pages (June 2016)
Fondaparinux (Arixtra∗) hepatotoxicity in a 6 year-old child
The dawn of a new EASL – A new chapter in the history of the European Association for the Study of the liver  Tom H. Karlsen, Phil N. Newsome  Journal.
Presentation transcript:

Coffee and tea breaks for liver health Salvatore Petta, Giulio Marchesini  Journal of Hepatology  Volume 67, Issue 2, Pages 221-223 (August 2017) DOI: 10.1016/j.jhep.2017.04.014 Copyright © 2017 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Sources of caffeine and amount per serving in coffee, tea and other beverages. Data are expressed as minimum, maximum and average (in red), according to different preparations and brands. Redrawn and modified from data of the Institute for Scientific Information on Coffee (www.coffeeandhealth.org). Note that the amount of caffeine in decaffeinated coffee and hot chocolate is negligible (<10mg/serving). Journal of Hepatology 2017 67, 221-223DOI: (10.1016/j.jhep.2017.04.014) Copyright © 2017 European Association for the Study of the Liver Terms and Conditions